DOI QR코드

DOI QR Code

Performance Characteristic of the β-Human Chorionic Gonadotropin Assay on the Access 2 for Its Use in Doping Control

  • Kang, Min-Jung (Integrated Omics Center, Korea Institute of Science and Technology) ;
  • Lee, Hye-Im (Doping control center, Korea Institute of Science and Technology) ;
  • Shin, Sang-Mi (Doping control center, Korea Institute of Science and Technology) ;
  • Yoo, Hye-Hyun (Department of Pharmacy, College of Pharmacy, Hanyang University) ;
  • Kwon, Oh-Seung (Doping control center, Korea Institute of Science and Technology) ;
  • Jin, Chang-Bae (Integrated Omics Center, Korea Institute of Science and Technology) ;
  • Chung, Bong-Chul (Integrated Omics Center, Korea Institute of Science and Technology)
  • Received : 2010.07.21
  • Accepted : 2010.08.23
  • Published : 2010.10.20

Abstract

The objective of this study was to validate performance characteristics of the Access 2 (Beckman coulter) system for hCG assays for use as a confirmation test for doping control. The Access 2 assay was linear up to 500 IU/L. The correlation coefficient was higher than 0.999, and the sensitivity of the linearity was 0.82. There were no false positive or false negative cases. LOD was 0.59 IU/L. The method was robust when performed by different people. Repeatability and reproducibility were below 7%. We compared reproducibility and recoveries of Access 2 and Elecsys 2010. Access 2 demonstrated higher reproducibility than Elecsys 2010. Recoveries (accuracy) of Access 2 were between 85 and 105%. Recoveries for Elecsys 2010 were between 91 and 104%.

Keywords

References

  1. Cole, L. A. Clin. Chem. 1997, 43, 2233.
  2. Stenman, U. H.; Tiitinen, A.; Alfthan, H.; Valmu, L. Hum. Reprod. 2006, 12, 769. https://doi.org/10.1093/humupd/dml029
  3. Cowan, D. A.; Kicman, A. T.; Walker, C. J.; Wheeler, M. J. J. Endocrinol. 1991, 131, 147. https://doi.org/10.1677/joe.0.1310147
  4. De Boer, D.; De Jong, E. G.; Van Rossum, J. M.; Maes, R. A. A. Int. J. Sports Med. 1991, 12, 46. https://doi.org/10.1055/s-2007-1024654
  5. Kicman, A. T.; Brooks, R. V.; Cowan, D. A. Br. J. Sports Med. 1991, 25, 73. https://doi.org/10.1136/bjsm.25.2.73
  6. Laidler, P.; Cowan, D. A.; Hider, R. C.; Kicman, A. T. Clin. Chem. 1994, 40, 1306.
  7. Gam, L. H.; Tham, S. Y.; Latiff, A. J. Chromatogr. B Analyst. Technol. Biomed. Life Sci. 2003, 792, 187. https://doi.org/10.1016/S1570-0232(03)00264-2
  8. Delbeke, F. T.; Van Eenoo, P.; De Backer, P. Int. J. Sports Med. 1998, 19, 287. https://doi.org/10.1055/s-2007-971920
  9. World Anti-doping Agency; http://www.wada-ama.org.
  10. Stenman, U.-H.; Unkila-Kallio, L.; Korhonen, J.; Alfthan, H. Clin. Chem. 1997, 43, 1293.
  11. Shahzad, K.; Kim, D.-H.; Kang, M.-J. Clin. Biochem. 2007, 40, 1259. https://doi.org/10.1016/j.clinbiochem.2007.06.015
  12. Guidelines for the validation and verification of chemical test methods, NATA Guidelines Technical note 17.